| p53 isoforms can regulate p53 transcriptional activity JC Bourdon, K Fernandes, F Murray-Zmijewski, G Liu, A Diot, ... Genes & development 19 (18), 2122-2137, 2005 | 1053 | 2005 |
| Arginine methylation controls growth regulation by E2F‐1 EC Cho, S Zheng, S Munro, G Liu, SM Carr, J Moehlenbrink, YC Lu, ... The EMBO journal 31 (7), 1785-1797, 2012 | 258 | 2012 |
| Regulation of nucleolar signalling to p53 through NEDDylation of L11 A Sundqvist, G Liu, A Mirsaliotis, DP Xirodimas EMBO reports 10 (10), 1132-1139, 2009 | 141 | 2009 |
| NUB1 promotes cytoplasmic localization of p53 through cooperation of the NEDD8 and ubiquitin pathways G Liu, DP Xirodimas Oncogene 29 (15), 2252-2261, 2010 | 74 | 2010 |
| NEDDylation regulates E2F‐1‐dependent transcription SJ Loftus, G Liu, SM Carr, S Munro, NB La Thangue EMBO reports 13 (9), 811-818, 2012 | 71 | 2012 |
| A regulatory circuit that involves HR23B and HDAC6 governs the biological response to HDAC inhibitors M New, H Olzscha, G Liu, O Khan, L Stimson, J McGouran, D Kerr, ... Cell Death & Differentiation 20 (10), 1306-1316, 2013 | 52 | 2013 |
| The p53 isoforms are differentially modified by Mdm2 S Camus, S Menéndez, K Fernandes, N Kua, G Liu, DP Xirodimas, ... Cell Cycle 11 (8), 1646-1655, 2012 | 46 | 2012 |
| The p66 and p12 subunits of DNA polymerase δ are modified by ubiquitin and ubiquitin-like proteins G Liu, E Warbrick Biochemical and biophysical research communications 349 (1), 360-366, 2006 | 43 | 2006 |
| The small molecules targeting ubiquitin-proteasome system for cancer therapy N Ao, Q Chen, G Liu Combinatorial chemistry & high throughput screening 20 (5), 403-413, 2017 | 31 | 2017 |
| Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response W Barczak, SM Carr, G Liu, S Munro, A Nicastri, LN Lee, C Hutchings, ... Nature Communications 14 (1), 1078, 2023 | 26 | 2023 |
| Arginine methylation expands the regulatory mechanisms and extends the genomic landscape under E2F control AP Roworth, SM Carr, G Liu, W Barczak, RL Miller, S Munro, A Kanapin, ... Science advances 5 (6), eaaw4640, 2019 | 25 | 2019 |
| Immune modulation underpins the anti‐cancer activity of HDAC inhibitors W Blaszczak, G Liu, H Zhu, W Barczak, A Shrestha, G Albayrak, S Zheng, ... Molecular Oncology 15 (12), 3280-3298, 2021 | 20 | 2021 |
| Genome-wide profiling of the toxic effect of bortezomib on human esophageal carcinoma epithelial cells N Ao, Y Dai, Q Chen, Y Feng, J Yu, C Wang, F Liu, M Li, G Liu Technology in Cancer Research & Treatment 18, 1533033819842546, 2019 | 7 | 2019 |
| The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity G Liu, W Barczak, LN Lee, A Shrestha, NM Provine, G Albayrak, H Zhu, ... Communications Biology 6 (1), 102, 2023 | 3 | 2023 |
